Business Daily from THE HINDU group of publications
Thursday, February 7, 2008
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

News Update as at 18.00 hrs (IST)


Corporate
Ranbaxy gets tentative nod to sell generic nexium in U.S.

MUMBAI: Ranbaxy Laboratories Ltd received tentative approval from the Food and Drug Administration (USFDA) to sell its copy of AstraZeneca Plc's ulcer treatment Nexium in the U.S.

The Gurgaon-based company received initial approval to sell 20 milligram and 40- milligram delayed-release capsules of esomeprazole magnesium in the U.S., it said today.

Prev: Aditya Birla to allot preferential shares
Next: Glenmark sees $60 m in milestone profits in FY-09

Business Line | NUS Index |

Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line